ZEA manufactures plant biologics for pharmaceutical uses providing wellness to the world. At ZEA, we are uprooting medicine by growing plants and using our proprietary technology to produce medicinal plant products and we offer superior data analytics in what is a $400 billion dollar market.
Location: United States, Massachusetts, Walpole
Employees: 11-50
Founded date: 2015
Investors 1
| Date | Name | Website |
| - | Valterra P... | valterrapa... |
Mentions in press and media 4
| Date | Title | Description |
| 12.02.2024 | Zea Biosciences Appoints Charles Legg as CEO | Legg's extensive background in biosciences, leadership, experience, and visionary approach will move the company forward while helping to improve global health. our proprietary manufacturing platform is a step forward to addressing some imp... |
| 28.03.2023 | Zea Biosciences Signs Exclusive License Agreement with the University of Pennsylvania for Hemophilia A, B Oral Tolerance Programs | WALPOLE, Mass. (PRWEB) March 28, 2023 Zea Biosciences, a Boston-based biopharmaceutical company with a new platform for biologics and vaccine development, has signed an exclusive license agreement with the University of Pennsylvania and the... |
| 21.02.2023 | Zea Signs with The University of Pennsylvania Exclusive License Agreement for Hemophilia A and B Therapeutic Programs | Strategic partnership accelerates the development of biologic therapeutics for Hemophilia A and B patients WALPOLE, MA, USA, February 21, 2023 /EINPresswire.com/ -- Zea Biosciences, a Boston-based biopharmaceutical company with a new platfo... |
| 13.09.2022 | Zea Biosciences Launches Master Research Collaboration Agreement with Loma Linda University Health | “The results from this could allow us to fundamentally change manufacturing and the way a product is managed; the hope is we can make a cheaper drug and offer that benefit for everyone, providing wellness across the world.” BOSTON (PRWEB) S... |